GuidelineBMC pediatrics2026
Recommendations for the community-based management of prolonged convulsive seizures in children in Europe.
Guideline in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Typically, convulsive epileptic seizures self-terminate within 2–3 min. A duration exceeding 5 min defines convulsive status epilepticus (CSE), a condition that could have detrimental neurological, cognitive and psychiatric consequences. As seizure duration extends towards 5 min, the risk of progression to CSE increases. A prolonged convulsive seizure (PCS) represents a medical emergency with a need for urgent treatment since the chances of spontaneous cessation are low. Generally, a PCS exceeding 5 min should be promptly treated with a rescue medication. However, for those who have already experienced a PCS, or who are at particular risk of a PCS, time to rescue medication administration should be individualized. Buccal midazolam and rectal diazepam are the current first line rescue medications available to treat PCS in Europe in the community setting. Given its ease of administration and social acceptability, buccal midazolam is currently considered by caregivers and neurologists the preferred rescue medication option in the community for children older than 6 months. This document contains the first expert panel recommendations for the management of PCS in children in the community in Europe, including an algorithm for the management of pediatric patients after the first PCS, and provides guidance for a seizure action plan (SAP).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.